HOSPITAL UNIVERSITARIO RUBER
Saila
Baylor University Medical Center
Dallas, Estados UnidosBaylor University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study
Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404